Imaging mimickers of cholangiocarcinoma: a pictorial review (original) (raw)

References

  1. Khan, S. A., S. Tavolari and G. Brandi (2019). Cholangiocarcinoma: Epidemiology and risk factors. Liver Int 39 Suppl 1: 19-31.
    PubMed Google Scholar
  2. Yamasaki, S. (2003). Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10(4): 288-291.
    PubMed Google Scholar
  3. Tajima, Y., T. Kuroki, K. Fukuda, N. Tsuneoka, J. Furui and T. Kanematsu (2004). An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma. Br J Surg 91(1): 99-104.
    CAS PubMed Google Scholar
  4. Morimoto, Y., Y. Tanaka, T. Ito, M. Nakahara, H. Nakaba, T. Nishida, M. Fujikawa, S. Yamamoto and T. Kitagawa (2003). Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10(6): 432-440.
    PubMed Google Scholar
  5. Banales, J. M., J. J. G. Marin, A. Lamarca, P. M. Rodrigues, S. A. Khan, L. R. Roberts, V. Cardinale, G. Carpino, J. B. Andersen, C. Braconi, D. F. Calvisi, M. J. Perugorria, L. Fabris, L. Boulter, R. I. R. Macias, E. Gaudio, D. Alvaro, S. A. Gradilone, M. Strazzabosco, M. Marzioni, C. Coulouarn, L. Fouassier, C. Raggi, P. Invernizzi, J. C. Mertens, A. Moncsek, S. Rizvi, J. Heimbach, B. G. Koerkamp, J. Bruix, A. Forner, J. Bridgewater, J. W. Valle and G. J. Gores (2020). Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17(9): 557-588.
    PubMed PubMed Central Google Scholar
  6. Kendall, T., J. Verheij, E. Gaudio, M. Evert, M. Guido, B. Goeppert and G. Carpino (2019). Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int 39 Suppl 1: 7-18.
    CAS PubMed Google Scholar
  7. Ishii, T., T. Ito, S. Sumiyoshi, S. Ogiso, K. Fukumitsu, S. Seo, K. Taura and S. Uemoto (2020). Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma. World J Surg Oncol 18(1): 319.
    PubMed PubMed Central Google Scholar
  8. Blechacz, B. (2017). Cholangiocarcinoma: Current Knowledge and New Developments. Gut Liver 11(1): 13-26.
    PubMed Google Scholar
  9. Chung, Y. E., M. J. Kim, Y. N. Park, J. Y. Choi, J. Y. Pyo, Y. C. Kim, H. J. Cho, K. A. Kim and S. Y. Choi (2009). Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29(3): 683-700.
    PubMed Google Scholar
  10. Lee, W. J., H. K. Lim, K. M. Jang, S. H. Kim, S. J. Lee, J. H. Lim and I. W. Choo (2001). Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 21 Spec No: S97-S116.
  11. Lee, J. J., S. T. Schindera, H. J. Jang, S. Fung and T. K. Kim (2017). Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis. Abdom Radiol (NY) 42(12): 2898-2908.
    Google Scholar
  12. Kim, D. H., S. H. Choi, S. H. Park, K. W. Kim, J. H. Byun, S. Y. Kim, S. S. Lee and J. I. Choi (2021). The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis. Eur Radiol 31(4): 2497-2506.
    PubMed Google Scholar
  13. Akita, M., K. Fujikura, T. Ajiki, T. Fukumoto, K. Otani, T. Azuma, T. Itoh, Y. Ku and Y. Zen (2017). Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas. Mod Pathol 30(7): 986-997.
    CAS PubMed Google Scholar
  14. Komuta, M., O. Govaere, V. Vandecaveye, J. Akiba, W. Van Steenbergen, C. Verslype, W. Laleman, J. Pirenne, R. Aerts, H. Yano, F. Nevens, B. Topal and T. Roskams (2012). Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology 55(6): 1876-1888.
    CAS PubMed Google Scholar
  15. Yu, X. R., W. Y. Huang, B. Y. Zhang, H. Q. Li and D. Y. Geng (2014). Differentiation of infiltrative cholangiocarcinoma from benign common bile duct stricture using three-dimensional dynamic contrast-enhanced MRI with MRCP. Clin Radiol 69(6): 567-573.
    PubMed Google Scholar
  16. Lee, J. W., J. K. Han, T. K. Kim, Y. H. Kim, B. I. Choi, M. C. Han, K. S. Suh and S. W. Kim (2000). CT features of intraductal intrahepatic cholangiocarcinoma. AJR Am J Roentgenol 175(3): 721-725.
    CAS PubMed Google Scholar
  17. Tang, A., O. Hallouch, V. Chernyak, A. Kamaya and C. B. Sirlin (2018). Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol (NY) 43(1): 13-25.
    Google Scholar
  18. Alexander, L. F., P. Harri, B. Little, C. C. Moreno and P. K. Mittal (2017). Magnetic Resonance Imaging of Primary Hepatic Malignancies in Patients With and Without Chronic Liver Disease: A Pictorial Review. Cureus 9(8): e1539.
    PubMed PubMed Central Google Scholar
  19. Bello, H. R., Z. K. Mahdi, S. K. Lui, S. B. Nandwana, P. A. Harri and A. H. Davarpanah (2021). Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology-Pathology Correlation. J Magn Reson Imaging. https://doi.org/10.1002/jmri.27553
    Article PubMed Google Scholar
  20. Lee, J. H., J. M. Lee, S. J. Kim, J. H. Baek, S. H. Yun, K. W. Kim, J. K. Han and B. I. Choi (2012). Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row CT: comparison with pathological differentiation. Br J Radiol 85(1017): e573-583.
    CAS PubMed PubMed Central Google Scholar
  21. Kim, J. H., I. Joo and J. M. Lee (2019). Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging. Korean J Radiol 20(7): 1019-1041.
    PubMed PubMed Central Google Scholar
  22. Wang, J., E. Li, H. Yang, J. Wu, H. C. Lu, C. Yi, J. Lei, W. Liao and L. Wu (2019). Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends. World J Surg Oncol 17(1): 43.
    PubMed PubMed Central Google Scholar
  23. Kim, T. H., H. Kim, I. Joo and J. M. Lee (2020). Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis. Korean J Radiol 21(10): 1115-1125.
    PubMed PubMed Central Google Scholar
  24. Sasaki, M., Y. Sato and Y. Nakanuma (2017). Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance. Histopathology 70(3): 423-434.
    PubMed Google Scholar
  25. Sammon, J., S. Fischer, R. Menezes, H. Hosseini-Nik, S. Lewis, B. Taouli and K. Jhaveri (2018). MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. Cancer Imaging 18(1): 8.
    PubMed PubMed Central Google Scholar
  26. Fowler, K. J., A. Sheybani, R. A. Parker, S. Doherty, E. M Brunt, W. C. Chapman and C. O. Menias (2013). Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol 201(2): 332-339.
    PubMed Google Scholar
  27. Kim, K. H., S. G. Lee, E. H. Park, S. Hwang, C. S. Ahn, D. B. Moon, T. Y. Ha, G. W. Song, D. H. Jung, K. M. Kim, Y. S. Lim, H. C. Lee, Y. H. Chung, Y. S. Lee and D. J. Suh (2009). Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol 16(3): 623-629.
    PubMed Google Scholar
  28. Doyle, D. J., K. Khalili, M. Guindi and M. Atri (2007). Imaging features of sclerosed hemangioma. AJR Am J Roentgenol 189(1): 67-72.
    PubMed Google Scholar
  29. Song, J. S., Y. N. Kim and W. S. Moon (2013). A sclerosing hemangioma of the liver. Clin Mol Hepatol 19(4): 426-430.
    PubMed PubMed Central Google Scholar
  30. Miyamoto, S., A. Oshita, Y. Daimaru, M. Sasaki, H. Ohdan and A. Nakamitsu (2015). Hepatic Sclerosed Hemangioma: a case report and review of the literature. BMC Surg 15: 45.
    PubMed PubMed Central Google Scholar
  31. Brancatelli, G., R. L. Baron, M. P. Federle, G. Sparacia and K. Pealer (2009). Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT. AJR Am J Roentgenol 192(5): 1341-1347.
    PubMed Google Scholar
  32. Zhang, S. L., C. Chen, Q. W. Rao, Z. Guo, X. Wang, Z. M. Wang and L. S. Wang (2020). Incidence, Prognostic Factors and Survival Outcome in Patients With Primary Hepatic Lymphoma. Front Oncol 10: 750.
    PubMed PubMed Central Google Scholar
  33. Maher, M. M., S. R. McDermott, H. M. Fenlon, D. Conroy, J. C. O'Keane, D. N. Carney and J. P. Stack (2001). Imaging of primary non-Hodgkin's lymphoma of the liver. Clin Radiol 56(4): 295-301.
    CAS PubMed Google Scholar
  34. Menias, C. O., V. R. Surabhi, S. R. Prasad, H. L. Wang, V. R. Narra and K. N. Chintapalli (2008). Mimics of cholangiocarcinoma: spectrum of disease. Radiographics 28(4): 1115-1129.
    PubMed Google Scholar
  35. Al-Khalili, O. M. and A. R. Erickson (2018). IgG-4 Related Disease: An Introduction. Mo Med 115(3): 253-256.
    PubMed PubMed Central Google Scholar
  36. Ma, M. X., V. Jayasekeran and A. K. Chong (2019). Benign biliary strictures: prevalence, impact, and management strategies. Clin Exp Gastroenterol 12: 83-92.
    CAS PubMed PubMed Central Google Scholar
  37. Levy, A. D., L. A. Murakata, R. M. Abbott and C. A. Rohrmann (2002). From the archives of the AFIP. Benign tumors and tumorlike lesions of the gallbladder and extrahepatic bile ducts: radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics 22(2): 387-413.
    PubMed Google Scholar
  38. Ebata, T., G. Ercolani, D. Alvaro, D. Ribero, L. Di Tommaso and J. W. Valle (2016). Current Status on Cholangiocarcinoma and Gallbladder Cancer. Liver Cancer 6(1): 59-65.
    PubMed PubMed Central Google Scholar
  39. Rawla, P., T. Sunkara, K. C. Thandra and A. Barsouk (2019). Epidemiology of gallbladder cancer. Clin Exp Hepatol 5(2): 93-102.
    PubMed PubMed Central Google Scholar
  40. Kondo, S., Y. Nimura, J. Kamiya, M. Nagino, M. Kanai, K. Uesaka and N. Hayakawa (2002). Mode of tumor spread and surgical strategy in gallbladder carcinoma. Langenbecks Arch Surg 387(5-6): 222-228.
    PubMed Google Scholar
  41. Padhiari, R. K., M. K. Ramesh, P. G P and N. Ahmed (2015). Tuberculosis biliary stricture simulating as cholangiocarcinoma. J Clin Diagn Res 9(3): PL01-02.
    PubMed PubMed Central Google Scholar
  42. Prasad, A. and K. K. Pandey (2001). Tuberculous biliary strictures: uncommon cause of obstructive jaundice. Australas Radiol 45(3): 365-368.
    CAS PubMed Google Scholar
  43. Joo, I., J. M. Lee and J. H. Yoon (2018). Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges. Radiology 288(1): 7-13.
    PubMed Google Scholar
  44. Ohtsuka, M., F. Kimura, H. Shimizu, H. Yoshidome, A. Kato, H. Yoshitomi, K. Furukawa, D. Takeuchi, T. Takayashiki, K. Suda, S. Takano, Y. Kondo and M. Miyazaki (2011). Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol 35(4): 512-521.
    PubMed Google Scholar
  45. Rocha, F. G., H. Lee, N. Katabi, R. P. DeMatteo, Y. Fong, M. I. D'Angelica, P. J. Allen, D. S. Klimstra and W. R. Jarnagin (2012). Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology 56(4): 1352-1360.
    CAS PubMed Google Scholar
  46. Wan, X. S., Y. Y. Xu, J. Y. Qian, X. B. Yang, A. Q. Wang, L. He, H. T. Zhao and X. T. Sang (2013). Intraductal papillary neoplasm of the bile duct. World J Gastroenterol 19(46): 8595-8604.
    PubMed PubMed Central Google Scholar
  47. Heffernan, E. J., T. Geoghegan, P. L. Munk, S. G. Ho and A. C. Harris (2009). Recurrent pyogenic cholangitis: from imaging to intervention. AJR Am J Roentgenol 192(1): W28-35.
    PubMed Google Scholar

Download references